Back

Glucose-lowering drugs and heart failure.

2 September 2019 (15:26 - 15:40)
Organised by:
Congress Presentation Part of: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD) Treatment Open Access ESC Congress 2019

About the speaker

Photo
Professor Petar Seferovic

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

4 More presentations in this session

Presentation thumbnail
What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
Professor F. Cosentino (Stockholm, SE)
Slides Video
Presentation thumbnail
Management of dyslipidaemias.
Doctor M. Lettino (Monza, IT)
Slides Video
Presentation thumbnail
New evidence from cardiovascular outcome trials.
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Benefits and risks of antithrombotic therapy in diabetes.
Professor B. Rocca (Casamassima, IT)
Slides Video

Access the full session

Session thumbnail
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

The Event

Event poster

ESC Congress 2019

2 September 2019 15:26 CET
You may be interested in
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios